Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 9.88%12.61B | 4.78%24.76B | 6.73%11.48B | 20.53%23.63B | 20.20%10.76B | 6.39%19.6B | 12.70%8.95B | 49.92%18.42B | 49.27%7.94B | -10.58%12.29B |
| Operating income | 9.88%12.61B | 4.78%24.76B | 6.73%11.48B | 20.53%23.63B | 20.20%10.76B | 6.39%19.6B | 12.70%8.95B | 49.92%18.42B | 49.27%7.94B | -10.58%12.29B |
| Cost of sales | -9.63%-10.79B | -6.51%-21.2B | -9.56%-9.84B | -22.87%-19.91B | -19.40%-8.99B | -3.06%-16.2B | -11.33%-7.53B | -54.18%-15.72B | -48.15%-6.76B | 10.51%-10.19B |
| Operating expenses | -9.63%-10.79B | -6.51%-21.2B | -9.56%-9.84B | -22.87%-19.91B | -19.40%-8.99B | -3.06%-16.2B | -11.33%-7.53B | -54.18%-15.72B | -48.15%-6.76B | 10.51%-10.19B |
| Gross profit | 11.42%1.82B | -4.48%3.55B | -7.63%1.64B | 9.39%3.72B | 24.46%1.77B | 25.70%3.4B | 20.54%1.42B | 29.18%2.71B | 55.97%1.18B | -10.91%2.09B |
| Selling expenses | -17.40%-262.93M | -11.38%-520.31M | -17.10%-223.95M | -33.08%-467.14M | -18.59%-191.25M | 5.12%-351.03M | 9.31%-161.27M | -30.64%-369.98M | -23.37%-177.83M | 21.31%-283.21M |
| Administrative expenses | 6.80%-888.74M | -3.14%-2.02B | -7.69%-953.63M | -7.50%-1.96B | -21.36%-885.51M | -27.67%-1.82B | -25.05%-729.65M | -15.81%-1.43B | -24.22%-583.5M | -10.96%-1.23B |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 479.12%23.74M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 479.12%23.74M |
| Impairment and provision | -61.25%-40.51M | -54.01%16.78M | -93.75%-25.12M | 162.09%36.48M | 67.72%-12.97M | 22.96%-58.75M | -125.92%-40.17M | 40.68%-76.26M | 25.52%-17.78M | -79.63%-128.56M |
| -Other impairment is provision | -61.25%-40.51M | -54.01%16.78M | -93.75%-25.12M | 162.09%36.48M | 67.72%-12.97M | 22.96%-58.75M | -125.92%-40.17M | 40.68%-76.26M | 25.52%-17.78M | -79.63%-128.56M |
| Special items of operating profit | -57.25%114.94M | 161.38%509.43M | 283.79%268.87M | -35.93%194.9M | -44.37%70.06M | -20.18%304.19M | 11.96%125.93M | 12.54%381.1M | -34.95%112.48M | 3.81%338.64M |
| Operating profit | 6.19%745.53M | 0.89%1.54B | -6.57%702.11M | 3.57%1.52B | 21.61%751.5M | 21.42%1.47B | 20.24%617.96M | 49.33%1.21B | 78.60%513.96M | -28.68%811.99M |
| Financing cost | 7.04%-44.68M | -11.62%-104.4M | -25.09%-48.07M | -16.24%-93.54M | -16.52%-38.43M | -14.26%-80.47M | 1.35%-32.98M | -57.44%-70.43M | -41.63%-33.43M | 28.01%-44.73M |
| Share of profits of associates | 537.53%14.68M | -62.00%9.88M | -119.45%-3.36M | 300.94%26M | 43,015.00%17.25M | 351.61%6.48M | -98.93%40K | -142.96%-2.58M | -11.45%3.74M | -35.99%6M |
| Earning before tax | 9.97%715.53M | -0.92%1.44B | -10.90%650.69M | 4.22%1.46B | 24.84%730.32M | 22.71%1.4B | 20.80%585.03M | 47.37%1.14B | 80.43%484.28M | -28.79%773.26M |
| Tax | 8.42%-134.49M | -2.17%-300.09M | 8.38%-146.86M | 6.27%-293.73M | -21.98%-160.29M | -35.56%-313.36M | -34.13%-131.41M | -11.65%-231.17M | -55.08%-97.97M | -12.28%-207.05M |
| After-tax profit from continuing operations | 15.33%581.04M | -1.70%1.14B | -11.61%503.83M | 7.25%1.16B | 25.66%570.03M | 19.44%1.08B | 17.43%453.62M | 60.43%908.39M | 88.23%386.31M | -37.19%566.21M |
| Earning after tax | 15.33%581.04M | -1.70%1.14B | -11.61%503.83M | 7.25%1.16B | 25.66%570.03M | 19.44%1.08B | 17.43%453.62M | 60.43%908.39M | 88.23%386.31M | -37.19%566.21M |
| Minority profit | 6.91%18.91M | -1.26%48.96M | 1,201.55%17.69M | 65.98%49.59M | -90.50%1.36M | 20.41%29.88M | 394.26%14.3M | 280.90%24.81M | 126.89%2.89M | -42.83%-13.72M |
| Profit attributable to shareholders | 15.63%562.13M | -1.71%1.09B | -14.51%486.14M | 5.58%1.11B | 29.45%568.67M | 19.41%1.06B | 14.58%439.32M | 52.36%883.58M | 77.51%383.41M | -36.34%579.92M |
| Basic earnings per share | 15.35%0.278 | -2.17%0.542 | -14.84%0.241 | 4.92%0.554 | 29.22%0.283 | 18.12%0.528 | 12.31%0.219 | 52.56%0.447 | 78.90%0.195 | -36.85%0.293 |
| Diluted earnings per share | 23.42%0.274 | 3.21%0.515 | -11.90%0.222 | 6.62%0.499 | 31.25%0.252 | 9.35%0.468 | -1.54%0.192 | 46.08%0.428 | 78.90%0.195 | -36.17%0.293 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | PwC accounting firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.